Search PubMed⌕ Search

Biomedical subjects

M Prager

Publications and source records attributed to M Prager.

32 records · Page 2Linked to original sources
PubMed1991

[The status of carotid artery surgery today: technique, indications, results].

Carotid artery endarterectomy (CAE) is a surgical standard procedure today. The indication is the symptomatic patient (Stage II) with transient ischemic attacks (TIA) and stenosis of the internal carotid artery (ACI). Data of several studies have yielded a highly restrictive policy toward operative procedures in asymptomatic patients (Stage I) with carotid bruit or ACI-stenosis. Furthermore there emerged wide consensus, that patients with frank stroke (Stage III) should not be operated upon. As diagnostic procedures highly advanced non invasive procedures came up during the last decade, as well as computerized tomography and digital subtraction angiography. The operative procedure is performed in general anesthesia with controlled hypertension during the clamping period (n = 650). Perioperative results without using a shunt are not different to those with a shunt. During the last 5 year period our results yielded a 1% perioperative central permanent neurological deficit rate (CPNDR) and a 1% operative mortality. During a 51 months median observation period 1.5% presented again with transient ischemic attacks-with TIA; 0.6% developed a stroke and 2.2% deceased by cerebral complications yielding at totally 4.3% long term complication rate. The annual rates are 0.3%, 0.1% respectively 0.5%, totally 0.9%. In conclusion CAE can be offered as a safe surgical stroke preventing procedure in symptomatic TIA patients with ACI stenoses in our institution. Perioperative as well as long term results are yielding a high standard and are clearly better than those without operation.

Carotid Artery Diseases↗
PubMed1991

[Effect of postoperative aggregation inhibiting therapy following carotid thrombendarterectomy on patient survival. Analysis after more than 15 years follow-up].

The patients in the clinical series as well as in the group with preoperative known cardiac risk receiving postoperative ASA medication yielded a significant better long-term survival results. ASA prolongs long-term survival after carotid endarterectomy. A postoperative ASA-therapy decreases the incidence of lethal cardiac complications.

Aspirin↗
PubMed1990

The many faces of AIDS: opportunities for intervention.

Social and cultural issues may have a profound impact on different populations' responses to the AIDS epidemic. To maximize their own effectiveness, clinicians need to be aware of special needs and concerns.

Acquired Immunodeficiency Syndrome↗
PubMed1990

Antiplatelet therapy following carotid bifurcation endarterectomy. Evaluation of a controlled clinical trial. Prognostic significance of histologic plaque examination on behalf of survival.

To determine whether antiplatelet therapy following carotid bifurcation endarterectomy influences postoperative survival and whether signs of progression in the plaques harvested at the time of surgery might be a prognostic indicator, a controlled clinical trial was undertaken. During 1982 to 1985, 66 patients were recruited, operated on (carotid endarterectomy) and assigned, using the method of adaptive randomisation to the therapy group (n = 32) receiving 1.0 g acetylsalicylic acid (ASA) per day, starting day two prior to surgery, or to the control group (n = 34), which remained without antiplatelet medication. The plaques harvested at the time of surgery were processed using standard histopathological methods and examined "blindly" by light microscopy for signs of arterio-sclerotic progression. The final endpoint was patient survival. The last assessment of the participants survival status was done by June 1989. During follow-up, 20 patients died, six in the treatment group and 14 in the untreated group, the difference being statistically significant (P less than 0.013 Breslow, P less than 0.029 Mantel). In 27 instances the histo-pathological examination showed signs of progression. In this subgroup ASA yielded a significant prolongation of patient survival (P less than 0.017 Breslow, P less than 0.048 Mantel). In the remaining patients no signs of cellular infiltration were evident and no influence of ASA on patient survival was demonstrable (P less than 0.503 Breslow, P less than 0.390 Mantel).

Aged↗
PubMed1990

Antiplatelet treatment prolongs survival after carotid bifurcation endarterectomy. Analysis of the clinical series followed by a controlled trial.

To examine the role of antiplatelet drugs in the secondary prevention of arteriosclerotic arterial disease following carotid endarterectomy, a clinical series (n = 252) was analyzed. Based on these results a prospective randomized trial was initiated, comparing the effect of antiplatelet drugs (acetyl-salicylic acid [ASA] 1000 mg/day) versus untreated controls. In both investigations patient survival was the primary end point. A cardiac risk (n = 91) implied a significant reduction in patient survival (p less than 0.019 Breslow, p less than 0.052 Mantel). Antiaggregating drugs prolonged survival in the collective series (p less than 0.0001 Breslow, p less than 0.0002 Mantel) and in the subgroup of patients with cardiac risk (p less than 0.014 Breslow, p less than 0.020 Mantel) as well. In the prospective trial 66 patients were recruited, receiving ASA (n = 32) versus no therapy (n = 34). During follow-up 15 patients died, 4 in the treatment, and 11 in the control group. Between both groups there was a significant difference in the probability of survival (p less than 0.021 Breslow, p less than 0.048 Mantel).

Aspirin↗
PubMed1990

Patency rate of implantable devices during long-term intraarterial chemotherapy.

Intraarterial implantable drug delivery systems have been considered as an alternative method for treating patients with unresectable liver malignancies. However, catheter problems with external implanted devices have resulted in limited application of chemotherapy. The introduction of subcutaneous devices offers an opportunity for long-term locoregional chemotherapy. Twelve external intraarterial catheters were implanted into 12 patients and 52 subcutaneously placed devices into 51 patients, all with various hepatic malignancies. Retrospective analyses comparing those two intraarterial systems were conducted taking into account the function and complication rate (hepatic artery thrombosis, infection, leaking, hemorrhage, and dislocation). The follow-up time for the external system was two to eight months (median five weeks), the thrombosis rate 33.3%, and the infection rate 25%. One instance of severe bleeding from the hepatic artery occurred during chemotherapy. One catheter dislocated. For the subcutaneously implanted intraarterial devices the follow-up time was five to forty-one months (median sixteen months), the thrombotic complication rate 17.3%, and the infection rate 7.6% (all patients with simultaneous bowel surgery). Catheter dislocation one year later required reimplantation; in 1 patient therapy had to be discontinued because of a catheter leak. The overall function rate was 71.3% with a median follow-up time of eight months. Anticoagulation therapy for subcutaneously implanted devices starting from the beginning of intraarterial chemotherapy is recommended to achieve long-term patency. No implantation should be preformed simultaneously with bowel surgery. The subcutaneously placed intraarterial devices had a higher function rate and were available for a longer period as compared with external implanted catheters.

Equipment Failure↗
PubMed1986

[Right atrial and ventricular thrombus formation in advanced left-side hypernephroma].

Hypernephromas may give rise to extensive thrombus formation in the inferior vena cava. In a 70-year-old female patient, two-dimensional echocardiography revealed a well-defined mass (2 X 2 cm in dimension) in the right atrium with occlusion of the tricuspid valve and thrombo-embolic material spreading from the inferior vena cava to the right atrium. This finding was confirmed by computed tomography and cavography. Computed tomography of the abdomen detected a large left-sided renal tumour and thrombotic occlusion of the whole vena cava. The patient was not willing to undergo surgery and the masses of thrombo-tumorous material in the right atrium and ventricle spread rapidly. Meanwhile a spontaneous recanalization of the oval foramen occurred. The patient died from massive pulmonary embolism. Only the signs and symptoms of right heart failure with confirmed thrombus formation in the right atrium led to the diagnosis of hypernephroma.

Aged↗